CID 16722836

Fedratinib

Structural Information

Molecular Formula
C27H36N6O3S
SMILES
CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4
InChI
InChI=1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31)
InChIKey
JOOXLOJCABQBSG-UHFFFAOYSA-N
Compound name
N-tert-butyl-3-[[5-methyl-2-[4-(2-pyrrolidin-1-ylethoxy)anilino]pyrimidin-4-yl]amino]benzenesulfonamide
Related CIDs

2D Structure

compound 2d structure
7
Annotation Hits

155
References

6655
Patents

524.25696 Da
Monoisotopic Mass

4.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 525.26424 224.3
[M+Na]+ 547.24618 227.3
[M-H]- 523.24968 232.6
[M+NH4]+ 542.29078 226.9
[M+K]+ 563.22012 220.9
[M+H-H2O]+ 507.25422 212.9
[M+HCOO]- 569.25516 236.8
[M+CH3COO]- 583.27081 249.4
[M+Na-2H]- 545.23163 226.8
[M]+ 524.25641 225.4
[M]- 524.25751 225.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe